MIG
VRTX icon

Mariner Investment Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Mariner Investment Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-54,500
Closed -$4.33M – 177
2016
Q1 		$4.33M Buy
54,500
+12,500
+30% +$1.13M 1.19% 27
2015
Q4 		$5.29M Buy
42,000
+12,000
+40% +$1.45M 1.17% 20
2015
Q3 		$3.12M Buy
30,000
+15,000
+100% +$1.93M 0.63% 52
2015
Q2 		$1.85M Buy
15,000
+5,000
+50% +$630K 0.47% 79
2015
Q1 		$1.18M Buy
+10,000
New +$1.2M 0.32% 89

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Mariner Investment Group's VRTX Position: Q2 2016 in Review

Mariner Investment Group sold out of Vertex Pharmaceuticals (VRTX) in Q2 2016, closing a stake of 54,500 shares — an estimated $4.33M sold.

Mariner Investment Group first reported a position in VRTX in Q1 2015 and held it in 5 quarters. The position peaked at $5.29M in Q4 2015. 482 funds tracked by Wall St. Rank hold VRTX as of Q2 2016.

  • Mariner Investment Group reported no remaining Vertex Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Mariner Investment Group sold 54,500 Vertex Pharmaceuticals shares in Q2 2016, an estimated $4.33M.
  • Mariner Investment Group first reported a position in Vertex Pharmaceuticals in Q1 2015 and held it in 5 quarters.
  • Mariner Investment Group's Vertex Pharmaceuticals position peaked at $5.29M in Q4 2015.
  • 482 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2016.

Based on Mariner Investment Group's 13F filing for Q2 2016, filed 3 Aug 2016.